scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.1997.15.4.1664 |
P698 | PubMed publication ID | 9193367 |
P2093 | author name string | F Cabanillas | |
W F Benedict | |||
M A Rodriguez | |||
W C Pugh | |||
A Majlis | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mantle cell lymphoma | Q268713 |
P304 | page(s) | 1664-1671 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants | |
P478 | volume | 15 |
Q35770272 | "In situ-like" mantle cell lymphoma: a report of two cases |
Q52730895 | A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial. |
Q50570119 | A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. |
Q24806620 | A rare case of breast carcinoma co-existing with axillary mantle cell lymphoma |
Q34107884 | Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens |
Q73345492 | Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy |
Q35211548 | Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission |
Q34183167 | Endoscopic features and prognoses of mantle cell lymphoma with gastrointestinal involvement |
Q33388563 | Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group |
Q78842144 | Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma |
Q28202773 | Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas I: Mantle cell lymphoma, follicular lymphoma, and Burkitt's lymphoma |
Q81141392 | Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients |
Q37474352 | Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909. |
Q36289029 | Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis |
Q35717870 | In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior |
Q39017105 | Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease |
Q44148372 | Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma |
Q28204304 | Limited-stage mantle-cell lymphoma |
Q30309451 | Mantle cell lymphoma |
Q35138873 | Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature |
Q38571854 | Mantle cell lymphoma--a spectrum from indolent to aggressive disease |
Q28256317 | Mantle cell lymphoma: observation to transplantation |
Q77788688 | Mantle-cell lymphoma |
Q34603567 | Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma |
Q36290246 | Molecular pathogenesis of mantle cell lymphoma |
Q36028745 | Proteasome inhibitors in mantle cell lymphoma |
Q26858960 | Risk factors for etiology and prognosis of mantle cell lymphoma |
Q43963780 | Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study. |
Q34487427 | Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials? |
Search more.